SEEL Seelos Therapeutics Inc

Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that they will present and host 1x1 and small group meetings at the Jefferies 2019 Global Healthcare Conference taking place June 4-7 at the Grand Hyatt in New York City. Chairman, Founder, and CEO Raj Mehra, PhD and Dr. Tim Whitaker, Seelos’ Head of Research and Development, will present and host the meetings.

About Seelos Therapeutics:

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.

For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Contact Information:

Anthony MarcianoHead of Corporate CommunicationsSeelos Therapeutics, Inc.(646) 293 2136anthony.marciano@seelostx.comwww.seelostherapeutics.comhttps://twitter.com/seelostxhttps://www.linkedin.com/company/seelos